Clinical Characteristics and Outcomes of SLE Patients Admitted to Critical Care Unit
NCT05418855 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2022-06-14
Summary
The aim of the present work is to determine the frequency of critical complications of SLE patients admitted to the intensive care unit,study the risk factors and out comes.
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Ahmed Bahy Ahmed, lecturer · Assiut University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-07-01
- Primary Completion
- 2023-01-01
- Completion
- 2023-02-01
More Related Trials
-
PRediction Of Flares In Lupus With autoantibodiEs and Chemokines
NCT04951427 ·Status: UNKNOWN
-
Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.
NCT06294483 ·Status: ENROLLING_BY_INVITATION
-
Effect of Gender on Clinical Presentation of SLE ِAt Assiut University Hospitals
NCT04234633 ·Status: UNKNOWN
-
Relation of Antibodies Against Oxidized Low Density Lipoproteins to Disease Activity and Cardiovascular Affection in Systemic Lupus.
NCT05479071 ·Status: UNKNOWN
-
Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Systemic Lupus Erythematosus Patients
NCT05971498 ·Status: UNKNOWN
-
A Study of Clinical Characteristics ,Risk Factors and Outcome of Lupus Nephritis Among Children With Systemic Lupus Erthromatousus in Sohag Univeristy Hospital
NCT06491602 ·Status: RECRUITING
-
Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients
NCT06610422 ·Status: NOT_YET_RECRUITING
-
IL17 in Systemic Lupus Erythematosus Patients: Association With Disease Activity and Organ Damage
NCT05045417 ·Status: UNKNOWN
-
The 2019 EULAR/ACR Classification Criteria as Predictor of Organ Damage in Systemic Lupus Erythematosus Patients
NCT06313151 ·Status: RECRUITING
-
Haematological Indices in Systemic Lupus Erythematosus
NCT04110184 ·Status: UNKNOWN
-
Urinary Congophilia As an Indicator of Activity of Lupus Nephritis
NCT06654024 ·Status: NOT_YET_RECRUITING
-
Fatigue in Systemic Lupus Erythematosus
NCT06652256 ·Status: COMPLETED
-
The Role of Some Hematological Parameters in Juvenile Systemic Lupue Erythematosus
NCT06227559 ·Status: NOT_YET_RECRUITING
-
Comparison of Clinical and Serological Differences Among Juvenile, Adult, and Late-onset Systemic Lupus Erythematosus
NCT05724940 ·Status: UNKNOWN
-
Assessment of CXCL5 Level in SLE Patients and Its Correlation with Disease Activity
NCT06610409 ·Status: NOT_YET_RECRUITING
-
Evaluation of Slit2 in Systemic Lupus Erythematosus and Systemic Sclerosis Patients
NCT05105217 ·Status: UNKNOWN
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Lupus Cohort--Thrombotic Events and Coronary Artery Disease
NCT00005436 ·Status: COMPLETED
-
Renal Survival in Patients with Lupus Nephritis
NCT06588192 ·Status: NOT_YET_RECRUITING
-
Serum IL 26 as a Marker of Disease Activity in SLE
NCT05161988 ·Status: UNKNOWN
-
Prediction of Relapse Risk in Stable Systemic Lupus Erythematosus
NCT02842814 ·Status: COMPLETED ·Phase: NA
-
GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus
NCT01992666 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort Study
NCT05588830 ·Status: UNKNOWN
-
O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus
NCT04440566 ·Status: COMPLETED ·Phase: NA
-
SLE Vasculitis In Egyptian Patients
NCT04386889 ·Status: UNKNOWN ·Phase: NA